相似文献
1
Botulinum Toxin in Pediatric Neurology: Switching Lanes From Death to Life.
Glob Pediatr Health. 2015 Jun 8;2:2333794X15590149. doi: 10.1177/2333794X15590149. eCollection 2015.
2
Current clinical applications of botulinum toxin.
Curr Pharm Des. 2009;15(31):3671-80. doi: 10.2174/138161209789271843.
3
Botulinum Neurotoxin Type A in Neurology: Update.
Neurol Int. 2015 Sep 24;7(2):5886. doi: 10.4081/ni.2015.5886.
4
From Toxin to Treatment: A Narrative Review on the Use of Botulinum Toxin for Autonomic Dysfunction.
Toxins (Basel). 2024 Feb 10;16(2):96. doi: 10.3390/toxins16020096.
5
[Mechanism of action and therapeutic uses of botulinum and tetanus neurotoxins].
Ann Pharm Fr. 2001 May;59(3):176-90.
6
Use of Clostridium botulinum toxin in gastrointestinal motility disorders in children.
World J Gastrointest Endosc. 2015 May 16;7(5):433-7. doi: 10.4253/wjge.v7.i5.433.
8
Expanding use of botulinum toxin.
J Neurol Sci. 2005 Aug 15;235(1-2):1-9. doi: 10.1016/j.jns.2005.04.017.
9
Current gaps in basic science knowledge of botulinum neurotoxin biological actions.
Toxicon. 2015 Dec 1;107(Pt A):59-63. doi: 10.1016/j.toxicon.2015.07.002. Epub 2015 Jul 7.
10
Botulinum toxin A and neuropathic pain: An update.
Toxicon. 2023 Aug 15;232:107208. doi: 10.1016/j.toxicon.2023.107208. Epub 2023 Jun 27.
引用本文的文献
1
Understanding Clinical Effectiveness and Safety Implications of Botulinum Toxin in Children: A Narrative Review of the Literature.
Toxins (Basel). 2024 Jul 4;16(7):306. doi: 10.3390/toxins16070306.
本文引用的文献
1
Botulinum toxin: The Midas touch.
J Nat Sci Biol Med. 2014 Jan;5(1):8-14. doi: 10.4103/0976-9668.127274.
2
A comparative assessment of three formulations of botulinum toxin A for facial rhytides: a systematic review and meta-analyses.
Syst Rev. 2013 Jun 13;2:40. doi: 10.1186/2046-4053-2-40.
3
Botulinum toxins: mechanisms of action, antinociception and clinical applications.
Toxicology. 2013 Apr 5;306:124-46. doi: 10.1016/j.tox.2013.02.006. Epub 2013 Feb 19.
4
Primary headache in children and adolescents: update on pharmacotherapy of migraine and tension-type headache.
Neuropediatrics. 2013 Feb;44(1):3-19. doi: 10.1055/s-0032-1330856. Epub 2013 Jan 9.
5
Clinical uses of botulinum neurotoxins: current indications, limitations and future developments.
Toxins (Basel). 2012 Oct;4(10):913-39. doi: 10.3390/toxins4100913. Epub 2012 Oct 19.
6
Evaluation of the effects of botulinum toxin A injections when used to improve ease of care and comfort in children with cerebral palsy whom are non-ambulant: a double blind randomized controlled trial.
BMC Pediatr. 2012 Aug 9;12:120. doi: 10.1186/1471-2431-12-120.
7
Current and future medical treatment in primary dystonia.
Ther Adv Neurol Disord. 2012 Jul;5(4):221-40. doi: 10.1177/1756285612447261.
8
Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis.
JAMA. 2012 Apr 25;307(16):1736-45. doi: 10.1001/jama.2012.505.
9
Therapeutic strategies in post-facial paralysis synkinesis in pediatric patients.
J Plast Reconstr Aesthet Surg. 2012 Aug;65(8):1009-18. doi: 10.1016/j.bjps.2012.03.026. Epub 2012 Apr 6.
10
Efficacy of laryngeal botulinum toxin injection: comparison of two techniques.
Laryngoscope. 2011 Sep;121(9):1924-8. doi: 10.1002/lary.21966. Epub 2011 Aug 16.
Zotero 插件